MEK activity regulates negative selection of immature CD4+CD8+ thymocytes
- PMID: 10679067
- DOI: 10.4049/jimmunol.164.5.2326
MEK activity regulates negative selection of immature CD4+CD8+ thymocytes
Abstract
CD4+CD8+ thymocytes are either positively selected and subsequently mature to CD4 single positive (SP) or CD8 SP T cells, or they die by apoptosis due to neglect or negative selection. This clonal selection is essential for establishing a functional self-restricted T cell repertoire. Intracellular signals through the three known mitogen-activated protein (MAP) kinase pathways have been shown to selectively guide positive or negative selection. Whereas the c-Jun N-terminal kinase and p38 MAP kinase regulate negative selection of thymocytes, the extracellular signal-regulated kinase (ERK) pathway is required for positive selection and T cell lineage commitment. In this paper, we show that the MAP/ERK kinase (MEK)-ERK pathway is also involved in negative selection. Thymocytes from newborn TCR transgenic mice were cultured with TCR/CD3epsilon-specific Abs or TCR-specific agonist peptides to induce negative selection. In the presence of the MEK-specific pharmacological inhibitors PD98059 or UO126, cell recovery was enhanced and deletion of DP thymocytes was drastically reduced. Furthermore, development of CD4 SP T cells was blocked, but differentiation of mature CD8 SP T cells proceeded in the presence of agonist peptides when MEK activity was blocked. Thus, our data indicate that the outcome between positively and negatively selecting signals is critically dependent on MEK activity.
Similar articles
-
CD5 costimulation up-regulates the signaling to extracellular signal-regulated kinase activation in CD4+CD8+ thymocytes and supports their differentiation to the CD4 lineage.J Immunol. 2000 Feb 1;164(3):1260-8. doi: 10.4049/jimmunol.164.3.1260. J Immunol. 2000. PMID: 10640739
-
Activation of the extracellular signal-related kinase/mitogen-activated protein kinase pathway discriminates CD4 versus CD8 lineage commitment in the thymus.J Immunol. 1999 Jul 15;163(2):715-22. J Immunol. 1999. PMID: 10395662
-
Role of CTLA-4 in the activation of single- and double-positive thymocytes.J Immunol. 2004 Dec 1;173(11):6645-53. doi: 10.4049/jimmunol.173.11.6645. J Immunol. 2004. PMID: 15557155
-
Positive and negative thymocyte selection.Crit Rev Immunol. 1998;18(4):359-70. doi: 10.1615/critrevimmunol.v18.i4.40. Crit Rev Immunol. 1998. PMID: 9704194 Review.
-
JNK and p38 MAP kinases in CD4+ and CD8+ T cells.Immunol Rev. 2003 Apr;192:131-42. doi: 10.1034/j.1600-065x.2003.00019.x. Immunol Rev. 2003. PMID: 12670401 Review.
Cited by
-
Kinase suppressor of Ras 1 is required for full ERK activation in thymocytes but not for thymocyte selection.Eur J Immunol. 2010 Nov;40(11):3226-34. doi: 10.1002/eji.201040349. Epub 2010 Sep 24. Eur J Immunol. 2010. PMID: 20865788 Free PMC article.
-
Mek2 is dispensable for mouse growth and development.Mol Cell Biol. 2003 Jul;23(14):4778-87. doi: 10.1128/MCB.23.14.4778-4787.2003. Mol Cell Biol. 2003. PMID: 12832465 Free PMC article.
-
T-cell receptor signaling is mediated by transient Lck activity, which is inhibited by inorganic mercury.FASEB J. 2009 Jun;23(6):1663-71. doi: 10.1096/fj.08-117283. Epub 2009 Jan 23. FASEB J. 2009. PMID: 19168706 Free PMC article.
-
Protein Kinase-Mediated Decision Between the Life and Death.Adv Exp Med Biol. 2021;1275:1-33. doi: 10.1007/978-3-030-49844-3_1. Adv Exp Med Biol. 2021. PMID: 33539010
-
Role of Ras/Raf/MEK/ERK signaling in physiological hematopoiesis and leukemia development.Immunol Res. 2011 Apr;49(1-3):248-68. doi: 10.1007/s12026-010-8187-5. Immunol Res. 2011. PMID: 21170740 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous